{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:08:20Z","timestamp":1783577300770,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11005-2","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T16:11:57Z","timestamp":1745597517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antibiotic susceptibility patterns of bacterial uropathogens at a private tertiary hospital in Uganda: a retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Rachael Mukisa","family":"Nakandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Kakeeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Bernard","family":"Kihumuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Marvin","family":"Kanyike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Racheal","family":"Nalunkuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald Samuel","family":"Lugwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Kasozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Muyanja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakiriba Rhoda","family":"Mayega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Kennedy","family":"Mutesasira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald Kasoma","family":"Mutebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiconco","family":"Patricia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Nasozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Namulema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robinson","family":"Ssebuufu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"11005_CR1","unstructured":"Organization WH. Antimicrobial resistance: global report on surveillance. World Health Organization; 2014."},{"key":"11005_CR2","doi-asserted-by":"crossref","unstructured":"Balala A, Huong T, Fenwick SJTVJ. Antibiotics resistance in sub saharan Africa; literature review from 2010\u20132017. 2019;37:35\u201345.","DOI":"10.4314\/tvj.v37i.6s"},{"issue":"7","key":"11005_CR3","doi-asserted-by":"publisher","first-page":"e1004264","DOI":"10.1371\/journal.pmed.1004264","volume":"20","author":"TR Walsh","year":"2023","unstructured":"Walsh TR, Gales AC, Laxminarayan R, Dodd PC. Antimicrobial resistance: addressing a global threat to humanity. PLoS Med. 2023;20(7):e1004264.","journal-title":"PLoS Med"},{"key":"11005_CR4","unstructured":"Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. 2022;399(10325):629\u201355."},{"key":"11005_CR5","doi-asserted-by":"crossref","unstructured":"Donkor ES, Horlortu PZ, Dayie NT, Obeng-Nkrumah N, Labi A-KJI, Resistance D. Community acquired urinary tract infections among adults in Accra, Ghana. 2019:2059-67.","DOI":"10.2147\/IDR.S204880"},{"key":"11005_CR6","doi-asserted-by":"crossref","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJJN. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. 2015;13(5):269\u201384.","DOI":"10.1038\/nrmicro3432"},{"key":"11005_CR7","doi-asserted-by":"crossref","unstructured":"Asafo-Adjei K, Mensah JE, Labi A-K, Dayie NT, Donkor ESJ. Urinary tract infections among bladder outlet obstruction patients in Accra, Ghana: aetiology, antibiotic resistance, and risk factors. 2018;6(3):65.","DOI":"10.3390\/diseases6030065"},{"key":"11005_CR8","doi-asserted-by":"crossref","unstructured":"Foxman B, Barlow R, D\u2019Arcy H, Gillespie B, Sobel JDJA. Urinary tract infection: self-reported incidence and associated costs. 2000;10(8):509\u201315.","DOI":"10.1016\/S1047-2797(00)00072-7"},{"issue":"11","key":"11005_CR9","first-page":"1028","volume":"366","author":"Hooton TMJNEJoM","year":"2012","unstructured":"Hooton TMJNEJoM. Uncomplicated Urinary Tract Infect. 2012;366(11):1028\u201337.","journal-title":"Uncomplicated Urinary Tract Infect"},{"key":"11005_CR10","doi-asserted-by":"crossref","unstructured":"Klein RD, Hultgren SJJNRM. Urinary tract infections: microbial pathogenesis, host\u2013pathogen interactions and new treatment strategies. 2020;18(4):211\u201326.","DOI":"10.1038\/s41579-020-0324-0"},{"issue":"3","key":"11005_CR11","first-page":"489","volume":"8","author":"J Tibyangye","year":"2015","unstructured":"Tibyangye J, Okech MA, Nyabayo JM, Nakavuma JLJBMRJ. In vitro antibacterial activity of Ocimum Suave essential oils against uropathogens isolated from patients in selected hospitals in Bushenyi district. Uganda. 2015;8(3):489.","journal-title":"Uganda"},{"issue":"4","key":"11005_CR12","first-page":"504","volume":"11","author":"F Carrasco Calzada","year":"2022","unstructured":"Carrasco Calzada F, Aguilera-Correa JJ, Cuadros Gonz\u00e1lez J, Esteban Moreno J, Roca Biosca D, P\u00e9rez-Tanoira R. Urinary tract infection and antimicrobial susceptibility of bacterial isolates in saint Joseph Kitgum hospital. Kitgum Uganda. 2022;11(4):504.","journal-title":"Kitgum Uganda"},{"issue":"2","key":"11005_CR13","first-page":"425","volume":"134","author":"A Manges","year":"2006","unstructured":"Manges A, Natarajan P, Solberg O, Dietrich P, Riley LJE. The changing prevalence of drug-resistant Escherichia coli clonal groups in a community: evidence for community outbreaks of urinary tract infections. Infection. 2006;134(2):425\u201331.","journal-title":"Infection"},{"key":"11005_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jgar.2021.02.021","volume":"25","author":"SB Obakiro","year":"2021","unstructured":"Obakiro SB, Kiyimba K, Paasi G, Napyo A, Anthierens S, Waako P, et al. Prevalence of antibiotic-resistant bacteria among patients in two tertiary hospitals in Eastern Uganda. J Global Antimicrob Resist. 2021;25:82\u20136.","journal-title":"J Global Antimicrob Resist"},{"issue":"1","key":"11005_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13756-022-01072-4","volume":"11","author":"D Chaplain","year":"2022","unstructured":"Chaplain D, Asutaku BB, Mona M, Bulafu D, Aruhomukama D. The need to improve antimicrobial susceptibility testing capacity in Ugandan health facilities: insights from a surveillance primer. Antimicrob Resist Infect Control. 2022;11(1):23.","journal-title":"Antimicrob Resist Infect Control"},{"key":"11005_CR16","unstructured":"Heuer O, Gunell M, Economopoulou A, Blomquist A, Brown D, Walton C et al. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2010. 2010:30\u2013\u20091."},{"key":"11005_CR17","doi-asserted-by":"crossref","unstructured":"Huang L, Huang C, Yan Y, Sun L, Li HJFM. Urinary tract infection etiological profiles and antibiotic resistance patterns varied among different age categories: a retrospective study from a tertiary general hospital during a 12-year period. 2022;12:813145.","DOI":"10.3389\/fmicb.2021.813145"},{"key":"11005_CR18","unstructured":"Huang L, Huang C, Yan Y, Sun L, Li HJFM. Clinical Guidelines 2023.pdf&gt."},{"issue":"8","key":"11005_CR19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1047-2797(00)00072-7","volume":"10","author":"B Foxman","year":"2000","unstructured":"Foxman B, Barlow R, D\u2019Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10(8):509\u201315.","journal-title":"Ann Epidemiol"},{"issue":"2","key":"11005_CR20","first-page":"75","volume":"3","author":"BH Oladeinde","year":"2011","unstructured":"Oladeinde BH, Omoregie R, Olley M, Anunibe JAJNA. Urinary Tract Infect Rural Community Nigeria. 2011;3(2):75.","journal-title":"Urinary Tract Infect Rural Community Nigeria"},{"issue":"4","key":"11005_CR21","first-page":"1131","volume":"16","author":"D Kabugo","year":"2016","unstructured":"Kabugo D, Kizito S, Ashok DD, Kiwanuka AG, Nabimba R, Namunana S, et al. Factors associated with community-acquired urinary tract infections among adults attending assessment centre. Mulago Hosp Uganda. 2016;16(4):1131\u201342.","journal-title":"Mulago Hosp Uganda"},{"key":"11005_CR22","doi-asserted-by":"crossref","unstructured":"Fourie JL, Claassen FM, Myburgh JJ. Causative pathogens and antibiotic resistance in community-acquired urinary tract infections in central South Africa. South African medical journal = Suid-Afrikaanse Tydskrif vir Geneeskunde. 2021;111(2):124\u20138.","DOI":"10.7196\/SAMJ.2021.v111i2.14905"},{"issue":"1","key":"11005_CR23","first-page":"17","volume":"43","author":"A Mancini","year":"2020","unstructured":"Mancini A, Pucciarelli S, Lombardi FE, Barocci S, Pauri P, Lodolini S. Differences between Community - and Hospital - acquired urinary tract infections in a tertiary care hospital. New Microbiol. 2020;43(1):17\u201321.","journal-title":"New Microbiol"},{"key":"11005_CR24","unstructured":"Mwaka AD, Mayanja-Kizza H, Kigonya E, Kaddu-Mulindwa DJA. Bacteriuria among adult non-pregnant women attending Mulago hospital assessment centre in Uganda. 2011;11(2)."},{"issue":"3","key":"11005_CR25","doi-asserted-by":"publisher","first-page":"e0265102","DOI":"10.1371\/journal.pone.0265102","volume":"17","author":"H Bizuayehu","year":"2022","unstructured":"Bizuayehu H, Bitew A, Abdeta A, Ebrahim S. Catheter-associated urinary tract infections in adult intensive care units at a selected tertiary hospital, addis Ababa, Ethiopia. PLoS ONE. 2022;17(3):e0265102.","journal-title":"PLoS ONE"},{"key":"11005_CR26","unstructured":"Ouma JJSPR. Prevalence and antimicrobial sensitivity of major bacteria associated with urinary tract infection among diabetic patients in Mulago Hospital. 2001."},{"key":"11005_CR27","doi-asserted-by":"crossref","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the infectious diseases society of America and the European society for microbiology and infectious diseases. 2011;52(5):e103\u201320.","DOI":"10.1093\/cid\/ciq257"},{"key":"11005_CR28","doi-asserted-by":"crossref","unstructured":"Nabadda S, Kakooza F, Kiggundu R, Walwema R, Bazira J, Mayito J et al. Implementation of the world health organization global antimicrobial resistance surveillance system in Uganda, 2015\u20132020: mixed-methods study using National surveillance data. 2021;7(10):e29954.","DOI":"10.2196\/29954"},{"key":"11005_CR29","doi-asserted-by":"crossref","unstructured":"Mwakyoma AA, Kidenya BR, Minja CA, Mushi MF, Sandeman A, Sabiti W et al. Allele distribution and phenotypic resistance to Ciprofloxacin and gentamicin among extended-spectrum \u03b2-lactamase-producing Escherichia coli isolated from the urine, stool, animals, and environments of patients with presumptive urinary tract infection in Tanzania. 2023;2:1164016.","DOI":"10.3389\/frabi.2023.1164016"},{"key":"11005_CR30","doi-asserted-by":"crossref","unstructured":"Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O\u2019Brien TF et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. 2005;5(8):481\u201393.","DOI":"10.1016\/S1473-3099(05)70189-4"},{"key":"11005_CR31","doi-asserted-by":"crossref","unstructured":"Kothari A, Sagar VJTJIDC. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study. 2008;2(05):354\u20138.","DOI":"10.3855\/jidc.196"},{"key":"11005_CR32","doi-asserted-by":"crossref","unstructured":"Kizito M, Lalitha R, Kajumbula H, Ssenyonga R, Muyanja D, Byakika-Kibwika P. Antibiotic prevalence study and factors influencing prescription of WHO watch category antibiotic ceftriaxone in a tertiary care private not for profit hospital in Uganda. Antibiot (Basel Switzerland). 2021;10(10).","DOI":"10.3390\/antibiotics10101167"},{"key":"11005_CR33","doi-asserted-by":"crossref","unstructured":"Sonda TB, Horumpende PG, Kumburu HH, van Zwetselaar M, Mshana SE, Alifrangis M et al. Ceftriaxone use in a tertiary care hospital in Kilimanjaro, Tanzania: A need for a hospital antibiotic stewardship programme. 2019;14(8):e0220261.","DOI":"10.1371\/journal.pone.0220261"},{"key":"11005_CR34","doi-asserted-by":"crossref","unstructured":"Kutyabami P, Munanura EI, Kalidi R, Balikuna S, Ndagire M, Kaggwa B et al. Evaluation of the clinical use of ceftriaxone among in-patients in selected health facilities in Uganda. 2021;10(7):779.","DOI":"10.3390\/antibiotics10070779"},{"key":"11005_CR35","doi-asserted-by":"crossref","unstructured":"Abongomera G, Koller M, Musaazi J, Lamorde M, Kaelin M, Tasimwa HB et al. Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study. 2021;21:1\u20137.","DOI":"10.1186\/s12879-021-06865-3"},{"key":"11005_CR36","doi-asserted-by":"crossref","unstructured":"Meresa Bishaw B, Tegegne GT, Berha ABJI, Resistance D. Appropriate use of ceftriaxone in Sub-Saharan Africa: a systematic review. 2021:3477\u201384.","DOI":"10.2147\/IDR.S329996"},{"key":"11005_CR37","doi-asserted-by":"crossref","unstructured":"Bullens M, de Cerqueira Melo A, Raziq S, Lee J, Khalid G, Khan S et al. Antibiotic resistance in patients with urinary tract infections in Pakistan. 2022;12(1):48\u201352.","DOI":"10.5588\/pha.21.0071"},{"issue":"1","key":"11005_CR38","doi-asserted-by":"publisher","first-page":"dlab003","DOI":"10.1093\/jacamr\/dlab003","volume":"3","author":"AK Sugianli","year":"2021","unstructured":"Sugianli AK, Ginting F, Parwati I, de Jong MD, van Leth F, Schultsz C. Antimicrobial resistance among uropathogens in the Asia-Pacific region: a systematic review. JAC-antimicrobial Resist. 2021;3(1):dlab003.","journal-title":"JAC-antimicrobial Resist"},{"key":"11005_CR39","doi-asserted-by":"crossref","unstructured":"Elshamy AA, Aboshanab KM, Yassien MA, Hassouna NAJAPSASU. Prevalence of carbapenem resistance among multidrug-resistant Gram-negative uropathogens. 2018;2(2):70\u20137.","DOI":"10.21608\/aps.2018.18736"},{"issue":"6","key":"11005_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3810\/pgm.2010.11.2217","volume":"122","author":"MS Bader","year":"2010","unstructured":"Bader MS, Hawboldt J, Brooks A. Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgrad Med. 2010;122(6):7\u201315.","journal-title":"Postgrad Med"},{"key":"11005_CR41","doi-asserted-by":"crossref","unstructured":"Huttner A, Verhaegh EM, Harbarth S, Muller AE, Theuretzbacher U, Mouton JWJJAC. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. 2015;70(9):2456\u201364.","DOI":"10.1093\/jac\/dkv147"},{"issue":"728","key":"11005_CR42","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.3399\/BJGP.2022.0354","volume":"73","author":"TN Platteel","year":"2023","unstructured":"Platteel TN, Beets MT, Teeuwissen HA, van de Doesschate TT, Venekamp RP, et al. Nitrofurantoin failure in males with an uncomplicated urinary tract infection: a primary care observational cohort study. Br J Gen Pract. 2023;73(728):e204\u201310.","journal-title":"Br J Gen Pract"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11005-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11005-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11005-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T16:12:10Z","timestamp":1745597530000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11005-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11005"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11005-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflicting interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethical principles of involvement of human research subjects as outlined in the Nuremberg Code and Declaration of Helsinki were strictly adhered to for this study. Ethical approval was obtained from the Mengo Hospital research and ethics committee under approval number MH-2023-27. Additional approval was obtained from the data manager to access patients\u2019 records from the hospital health management information system. A waiver of consent was written and approved for the use of patient information for the study by the ethics committee of the hospital. Patients\u2019 records were reviewed, and confidentiality was maintained. Clinical trial number: not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"605"}}